DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN
» See Plans and Pricing
All Clinical Trials for Insulatard Nph Human
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00346996 | Insulin Analogues and Severe Hypoglycaemia | Completed | Novo Nordisk A/S | Phase 4 | 2007-05-01 | Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia |
NCT00346996 | Insulin Analogues and Severe Hypoglycaemia | Completed | Lise Tarnow | Phase 4 | 2007-05-01 | Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia |
NCT00566124 | Basal Insulins - Pharmacodynamics | Completed | Novo Nordisk A/S | Phase 4 | 2005-01-01 | To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection. |
NCT00566124 | Basal Insulins - Pharmacodynamics | Completed | The Danish Diabetes Association | Phase 4 | 2005-01-01 | To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection. |
NCT00566124 | Basal Insulins - Pharmacodynamics | Completed | The Institute of Experimental Clinical Research, University of Aarhus | Phase 4 | 2005-01-01 | To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection. |
NCT00566124 | Basal Insulins - Pharmacodynamics | Completed | University of Aarhus | Phase 4 | 2005-01-01 | To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection. |
NCT00657930 | Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) | Completed | Novo Nordisk A/S | N/A | 2008-03-01 | This study is conducted in Europe. The aim of this observational study is to gain practical experience with once-daily Levemir administration in type 2 diabetes patients who were previously treated with Insulatard®, Humulin® N (NPH insulins) as basal insulin as part of their ICT under normal clinical practice conditions in Hungary. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Insulatard Nph Human
Condition Name
Condition MeSH
Clinical Trial Locations for Insulatard Nph Human
Clinical Trial Progress for Insulatard Nph Human
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Insulatard Nph Human
Sponsor Name